Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging
Jay H. Traverse, Timothy D. Henry, Lemuel A. Moye'Volume:
162
Year:
2011
Language:
english
Pages:
678
DOI:
10.1016/j.ahj.2011.06.019
File:
PDF, 154 KB
english, 2011